Reuters logo
BRIEF-Crispr Therapeutics - Marc Becker, senior vice president, CFO will go on family, medical leave of absence, effective March 21, 2017,
2017年3月20日 / 晚上8点55分 / 8 个月前

BRIEF-Crispr Therapeutics - Marc Becker, senior vice president, CFO will go on family, medical leave of absence, effective March 21, 2017,

March 20 (Reuters) - Crispr Therapeutics AG:

* Crispr Therapeutics AG- effective March 21, 2017, Marc Becker, senior vice president and CFO will go on a family and medical leave of absence

* Crispr Therapeutics AG- currently plans to provide an update on status of Becker’s leave of absence prior to end of q2 - sec filing

* Crispr Therapeutics AG- during Becker's leave of absence Samarth Kulkarni Co's chief business officer will serve as acting principal financial officer Source text (bit.ly/2mNH33R) Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below